Skip to content

MEDIPEL

Active
Private limited companyfounded 20232 yrs activePittemstraat 33, 9880 Aalter, BelgiumKBO/BCE: BE 1001.657.830
Summary

MEDIPEL has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €220,782 and a net result of €157,646. Its solvency ranks better than 65% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+5
Growth78
Track record82
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21,000 at 30 days only on tighter terms
Liquidity ample (current ratio 3.86 against 3.02 in 2024; short-term debt: 23.1% and cash: 86.6% of total assets), and 23.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
76.8%
Return on assets
54.8%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-12-2025, 43 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
43 d early
2024
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 22 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close29-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

MEDIPEL was incorporated on 26 October 2023 as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€220,782▲ 245%
2024 · €63,996
Total assets
€287,610▲ 214%
2024 · €91,736
Net result
€157,646▲ 151%
2024 · €62,826
Working capital
€190,424▲ 241%
2024 · €55,814
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result€78,921-€207,236▲ 163%
Net result€62,826within the sector's middle half-€157,646above the sector's middle half▲ 151%
Equity€63,996within the sector's middle half-€220,782within the sector's middle half▲ 245%
Total assets€91,736below the sector's middle half-€287,610within the sector's middle half▲ 214%
Debt€27,740-€66,828▲ 141%
Working capital€55,814within the sector's middle half-€190,424within the sector's middle half▲ 241%
Solvency69.8%within the sector's middle half-76.8%within the sector's middle half▲ 7.0pp
Current ratio3.02within the sector's middle half-3.86within the sector's middle half▲ 0.84
Return on assets (ROA)68.5%above the sector's middle half-54.8%above the sector's middle half▼ 13.7pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2024: €78,921€78,921Net result 2024: €62,826€62,826Operating result 2025: €207,236€207,236Net result 2025: €157,646€157,64620242025€0€100,000€200,000Operating result 2024: €78,921€78,900Net result 2024: €62,826€62,800Operating result 2025: €207,236€207,000Net result 2025: €157,646€158,00020242025
The operating result rises in 2025; 2025 is 163% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €285,277
Fixed assets €28,354 ▲ 435%
Current assets €256,923 ▲ 208%
Equity and liabilities €287,610
Equity €220,782 ▲ 245%
Debt €66,828 ▲ 141%
Debt's share of the balance-sheet total falls from 30.2% to 23.2%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€213,558▲
2024 · €80,367
Cash flow
€163,968▲
2024 · €64,272
Debt to equity
0.30▼
2024 · 0.43
ROE
71.4%▼
2024 · 98.2%
Interest coverage
110.43▼
2024 · 2133.44
Debt ≤ 1 year
€66,499▲
2024 · €27,603
Income taxes
€47,785▲
2024 · €16,057
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€91,736€287,610▲
Formation expenses20€3,021€2,333▼
Fixed assets21/28€5,299€28,354▲
Tangible fixed assets22/27€5,299€28,354▲
Plant, machinery and equipment23€3,624€2,786▼
Furniture and vehicles24€1,675€25,568▲
Current assets29/58€83,416€256,923▲
Cash at bank and in hand54/58€75,001€249,196▲
Deferred charges and accrued income490/1€8,415€7,727▼
Equity and liabilities
Total equity and liabilities10/49€91,736€287,610▲
Equity10/15€63,996€220,782▲
Contributions10/11€2,000€2,000=
Reserves13€61,996€218,782▲
Distributable reserves133€61,996€218,782▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€27,740€66,828▲
Amounts payable within one year42/48€27,603€66,499▲
Trade debts44€408€735▲
Suppliers440/4€408€735▲
Taxes, remuneration and social security45€16,614€33,857▲
Taxes450/3€16,614€33,857▲
Other amounts payable47/48€10,581€31,907▲
Accrued charges and deferred income492/3€137€329▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,446€6,322▲
Other operating charges640/8-€58
Gross operating margin9900€80,367€213,616▲
Operating profit (loss)9901€78,921€207,236▲
Financial income75/76B-€129
Recurring financial income75-€129
Financial charges65/66B€38€1,934▲
Recurring financial charges65€38€1,934▲
Profit (loss) for the period before taxes9903€78,883€205,431▲
Income taxes67/77€16,057€47,785▲
Profit (loss) for the period9904€62,826€157,646▲
Profit (loss) for the period to be appropriated9905€62,826€157,646▲
Appropriation of the result
Profit (loss) to be appropriated9906€62,826€157,646▲
Transfer to equity691/2€61,996€156,786▲
To other reserves6921€61,996€156,786▲
Profit to be distributed694/7€830€860▲
Return on contributions (dividend)694€830€860▲

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,446€6,322▲ 337%
Other operating charges640/8-€58-
Gross operating margin9900€80,367€213,616▲ 166%
Operating profit (loss)9901€78,921€207,236▲ 163%
Financial income75/76B-€129-
Recurring financial income75-€129-
Financial charges65/66B€38€1,934▲ 5,034%
Recurring financial charges65€38€1,934▲ 5,034%
Profit (loss) for the period before taxes9903€78,883€205,431▲ 160%
Income taxes67/77€16,057€47,785▲ 198%
Profit (loss) for the period9904€62,826€157,646▲ 151%
Profit (loss) for the period to be appropriated9905€62,826€157,646▲ 151%
Line20242025Change
Assets
Total assets20/58€91,736€287,610▲ 214%
Formation expenses20€3,021€2,333▼ 22.8%
Fixed assets21/28€5,299€28,354▲ 435%
Tangible fixed assets22/27€5,299€28,354▲ 435%
Plant, machinery and equipment23€3,624€2,786▼ 23.1%
Furniture and vehicles24€1,675€25,568▲ 1,426%
Current assets29/58€83,416€256,923▲ 208%
Cash at bank and in hand54/58€75,001€249,196▲ 232%
Deferred charges and accrued income490/1€8,415€7,727▼ 8.2%
Equity and liabilities
Total equity and liabilities10/49€91,736€287,610▲ 214%
Equity10/15€63,996€220,782▲ 245%
Contributions10/11€2,000€2,000=
Reserves13€61,996€218,782▲ 253%
Distributable reserves133€61,996€218,782▲ 253%
Profit (loss) carried forward14€0€0-
Amounts payable17/49€27,740€66,828▲ 141%
Amounts payable within one year42/48€27,603€66,499▲ 141%
Trade debts44€408€735▲ 80.2%
Suppliers440/4€408€735▲ 80.2%
Taxes, remuneration and social security45€16,614€33,857▲ 104%
Taxes450/3€16,614€33,857▲ 104%
Other amounts payable47/48€10,581€31,907▲ 202%
Accrued charges and deferred income492/3€137€329▲ 140%
Line20242025Change
Profit (loss) for the period9904€62,826€157,646▲ 151%
+ Depreciation and write-downs630€1,446€6,322▲ 337%
Operating cash flow (approximation)€64,272€163,968▲ 155%
Investment in fixed assets (approximation)--€29,377-
Change in cash-€174,195-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2025
19-12
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
30-06
Financial Equity above €200,000Eq €220,782 ▲245%
2 profitable years in a row build equity to €220,782.
31-01
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalter · 1 establishment unit since 2023
seat establishment The establishment unit on the map
Ground area
1,502 m²
Building footprint
421 m²
Volume, LiDAR
436 m³
2 parcels, Flanders · tallest building 5.7 m, ±1 floor. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
MEDIPEL
Steenweg op Deinze 178, 9880 AalterGeneral medical practice
since 20232.351.554.073
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44035C0017/00P002 Flanders 990 m² 1 · 306 m² -
44035C0019/00G000 Flanders 512 m² 1 · 115 m² 5.7 m · 1 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,130 companies in sector 86210 we hold annual accounts for 6,336. 5,338 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded26-10-2023
Fiscal year end30-06
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:1001657830
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.